0.50 (0.457%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Strong
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Inhibrx Biosciences, Inc.
Telephone
1.858.795.4220
Address
Suite 140, 11025 North Torrey Pines Road, La Jolla, CA 92037
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 12.24 - 155.29
Trade Value (12mth)
US$4,861,623.00
1 week
0.8%
1 month
30.25%
YTD
45.94%
1 year
732.14%
All time high
155.29
EPS 3 yr Growth
-9.90%
EBITDA Margin
NaN%
Operating Cashflow
-$130m
Free Cash Flow Return
-102.70%
ROIC
-110.80%
Interest Coverage
-10.90
Quick Ratio
3.90
Shares Outstanding (Fully Diluted)
16m
HALO Sector
Healthcare
Next Company Report Date
24-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 15 May 26 | |
| 15 May 26 | |
| 15 May 26 | |
| 15 May 26 | |
| 12 May 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -16.67 | 116.58 | -9.04 | | | | ||
EPS (Fully Diluted) | $ | | | | | -16.67 | 116.58 | -9.04 | | | | ||
Growth | % | | | | | -66.2 | 799.2 | -107.8 | | | | ||
PE | X | | | | | N/A | 0.1 | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
